On the cusp
Closing in on medical solutions — from preventing kidney stones to stopping Alzheimer’s and curing ovarian cancer
The path from an aha moment to a medical advance involves researchers climbing a series of confidence-building steps — each one meant to hone the resulting insights into a real-world patient benefit.
In this Research & Development section, we meet Stanford Medicine researchers who are on this path and spotlight their progress along the route, whether their stage is preclinical development, where they’re analyzing molecular mechanisms, refining models and designing interventions, or they’ve made it to clinical trials, where they’re putting early promise to the test in the place it matters most — among patients.
Research & Development
‘We need a breakthrough’
Trials of immunotherapy for ovarian cancer offer hope for patients with few options
Stopping kidney stones at the source
A Stanford nephrologist is developing drugs that could prevent kidney stones
A softer landing for stem cells
A new transplant approach could spare patients chemo and radiation risk
